QLT Plug Delivery, Inc.
|Information provided by:||QLT Plug Delivery, Inc.|
The purpose of this study is to determine if the Punctal Plug Delivery System is safe and effective in controlling intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
|Study Design:||Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study|
|Official Title:||An Open-Label, Phase 2 Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open Angle Glaucoma (OAG)|
|Study Start Date:||January 2009|
|Estimated Study Completion Date:||July 2009|
|Estimated Primary Completion Date:||July 2009 (Final data collection date for primary outcome measure)|
|Punctal plug: Experimental||
Control of IOP compared to baseline for the experimental dose of Latanoprost-PPDS for 4 months or until loss of efficacy.
|Contact: Oscar Cuzzani, MDfirstname.lastname@example.org|
|United States, Missouri|
|St. Louis, Missouri, United States, 63131|
|Study Director:||Oscar Cuzzani, MD||QLT Inc|